Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Engel · SciRah

Researcher profile · Semantic Scholar

S. Engel

Share profile

S. Engel — researcher profile on SciRah

h-index: 37
Works: 135
Citations: 8,338

Most-cited papers

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
J. Green, M. Bethel, P. Armstrong, J. Buse +16 more
2015New England Journal of Medicine2,301 citations Open access
Semantic Scholar
Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus
K. Iglay, Hakima Hannachi, Patrick Joseph Howie, Jin-Fang Xu +4 more
2016Current Medical Research and Opinion449 citations
Semantic Scholar
Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS
J. Cornel, G. Bakris, Susanna R. Stevens, M. Alvarsson +13 more
2016Diabetes Care170 citations
Semantic Scholar
A Phase 2a active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with nonalcoholic fatty liver disease.
M. Romero-Gómez, E. Lawitz, R. Shankar, E. Chaudhri +4 more
2023Journal of Hepatology166 citations Open access
Semantic Scholar
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
J. Green, M. Bethel, P. Armstrong, J. Buse +15 more
2015New England Journal of Medicine145 citations Open access
Semantic Scholar
Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study
G. Grunberger, S. Camp, Jeremy R Johnson, S. Huyck +6 more
2017Diabetes Therapy141 citations Open access
Semantic Scholar
Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo‐controlled randomized study
S. Dagogo-Jack, Jie Liu, R. Eldor, G. Amorin +9 more
2017Diabetes, obesity and metabolism137 citations Open access
Semantic Scholar
Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study
P. Hollander, Jie Liu, Julie Hill, Jeremy R Johnson +7 more
2017Diabetes Therapy110 citations Open access
Semantic Scholar
A randomized, placebo-controlled study of the cardiovascular safety of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus
I. Gantz, Meng-Hui Chen, S. Suryawanshi, Catherine Ntabadde +5 more
2017Cardiovascular Diabetology94 citations Open access
Semantic Scholar
Risk characterization for urinary tract infections in subjects with newly diagnosed type 2 diabetes.
A. Fu, K. Iglay, Ying Qiu, S. Engel +2 more
2014Journal of diabetes and its complications93 citations Open access
Semantic Scholar
Ertugliflozin and Sitagliptin Co-initiation in Patients with Type 2 Diabetes: The VERTIS SITA Randomized Study
Sam S. Miller, T. Krumins, Haojin Zhou, S. Huyck +6 more
2018Diabetes Therapy90 citations Open access
Semantic Scholar
Disease burden of urinary tract infections among type 2 diabetes mellitus patients in the U.S.
Shengsheng Yu, A. Fu, Ying Qiu, S. Engel +4 more
2014Journal of diabetes and its complications75 citations Open access
Semantic Scholar
Safety and Efficacy of Omarigliptin (MK-3102), a Novel Once-Weekly DPP-4 Inhibitor for the Treatment of Patients With Type 2 Diabetes
W. Sheu, I. Gantz, Meng-Hui Chen, S. Suryawanshi +4 more
2015Diabetes Care64 citations Open access
Semantic Scholar
Glucagon receptor antagonism induces increased cholesterol absorption[S]
Hong-Ping Guan, Xiaodong Yang, K. Lu, Sheng-Ping Wang +19 more
2015Journal of Lipid Research63 citations Open access
Semantic Scholar
Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
A. Bethel, S. Engel, J. Green, Zhen Huang +9 more
2017Diabetes Care56 citations Open access
Semantic Scholar
Pancreatic Safety of Sitagliptin in the TECOS Study
John B. Buse, M. Bethel, J. Green, Susanna R. Stevens +12 more
2016Diabetes Care56 citations Open access
Semantic Scholar
Sulfonylurea Use and Risk of Hip Fractures Among Elderly Men and Women with Type 2 Diabetes
S. Rajpathak, Chunmay Fu, K. Brodovicz, S. Engel +1 more
2015Drugs & Aging52 citations
Semantic Scholar
Assessing occurrence of hypoglycemia and its severity from electronic health records of patients with type 2 diabetes mellitus.
A. Nunes, Jing Yang, L. Radican, S. Engel +6 more
2016Diabetes Research and Clinical Practice50 citations
Semantic Scholar
Hypoglycaemia seriousness and weight gain as determinants of cardiovascular disease outcomes among sulfonylurea users
A. Nunes, K. Iglay, L. Radican, S. Engel +3 more
2017Diabetes, obesity and metabolism49 citations
Semantic Scholar
A randomized clinical trial of the efficacy and safety of sitagliptin compared with dapagliflozin in patients with type 2 diabetes mellitus and mild renal insufficiency: The CompoSIT‐R study
R. Scott, J. Morgan, Z. Zimmer, Raymond L. H. Lam +4 more
2018Diabetes, obesity and metabolism48 citations Open access
Semantic Scholar
Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
M. Bethel, J. Green, J. Milton, A. Tajar +3 more
2015Diabetes, obesity and metabolism43 citations
Semantic Scholar
Results of VERTIS SU extension study: safety and efficacy of ertugliflozin treatment over 104 weeks compared to glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin
P. Hollander, Julie Hill, Jeremy R Johnson, Zhi-Wei Jiang +7 more
2019Current Medical Research and Opinion37 citations Open access
Semantic Scholar
Randomized clinical trial of the safety and efficacy of sitagliptin and metformin co‐administered to Chinese patients with type 2 diabetes mellitus
L. Ji, P. Han, Xiaoyue Wang, Jing-Dong Liu +7 more
2016Journal of Diabetes Investigation33 citations Open access
Semantic Scholar
Safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease: outcomes from TECOS
S. Engel, S. Suryawanshi, Susanna R. Stevens, R. Josse +7 more
2017Diabetes, obesity and metabolism32 citations
Semantic Scholar
Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS
J. Alfredsson, J. Green, Susanna R. Stevens, S. Reed +9 more
2018Diabetes, obesity and metabolism31 citations
Semantic Scholar
Impact of time to treatment intensification on glycemic goal attainment among patients with type 2 diabetes failing metformin monotherapy.
S. Rajpathak, Srini Rajgopalan, S. Engel
2014Journal of diabetes and its complications29 citations
Semantic Scholar
Impact of the severity of hypoglycemia on health - Related quality of life, productivity, resource use, and costs among US patients with type 2 diabetes.
M. Pawaskar, K. Iglay, E. Witt, S. Engel +1 more
2018Journal of diabetes and its complications28 citations
Semantic Scholar
Predictive modeling of hypoglycemia for clinical decision support in evaluating outpatients with diabetes mellitus
Xiaochun Li, Shengsheng Yu, Zuoyi Zhang, L. Radican +11 more
2019Current Medical Research and Opinion26 citations Open access
Semantic Scholar
A randomized, placebo‐ and sitagliptin‐controlled trial of the safety and efficacy of omarigliptin, a once‐weekly dipeptidyl peptidase‐4 inhibitor, in Japanese patients with type 2 diabetes
I. Gantz, T. Okamoto, Yuka Ito, K. Okuyama +4 more
2017Diabetes, obesity and metabolism26 citations Open access
Semantic Scholar
Randomized clinical trial comparing the efficacy and safety of treatment with the once‐weekly dipeptidyl peptidase‐4 (DPP‐4) inhibitor omarigliptin or the once‐daily DPP‐4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy
R. Goldenberg, I. Gantz, P. J. Andryuk, E. A. O'Neill +5 more
2017Diabetes, obesity and metabolism26 citations Open access
Semantic Scholar
A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes
R. Shankar, Philip Zeitler, A. Deeb, M. Y. Jalaludin +13 more
2021Pediatric Diabetes25 citations Open access
Semantic Scholar
Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin
M. Y. Jalaludin, A. Deeb, Philip Zeitler, Raymundo Garcia +13 more
2021Pediatric Diabetes24 citations Open access
Semantic Scholar
Urinary albumin excretion with sitagliptin compared to sulfonylurea as add on to metformin in type 2 diabetes patients with albuminuria: A real-world evidence study.
I. Goldshtein, A. Karasik, Cheli Melzer-Cohen, S. Engel +9 more
2016Journal of diabetes and its complications23 citations
Semantic Scholar
A randomised, double‐blind, trial of the safety and efficacy of omarigliptin (a once‐weekly DPP‐4 inhibitor) in subjects with type 2 diabetes and renal impairment
A. Chacra, I. Gantz, Geraldine Mendizabal, Lucila Durlach +5 more
2017International journal of clinical practice19 citations Open access
Semantic Scholar
Association between hypoglycemia risk and hemoglobin A1C in patients with type 2 diabetes mellitus
Shengsheng Yu, A. Fu, S. Engel, R. Shankar +1 more
2016Current Medical Research and Opinion18 citations
Semantic Scholar
Severity of hypoglycaemia and health‐related quality of life, work productivity and healthcare costs in patients with type 2 diabetes in Europe
M. Pawaskar, E. Witt, S. Engel, S. Rajpathak +1 more
2018Endocrinology, Diabetes & Metabolism17 citations Open access
Semantic Scholar
Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in People ≥ 65 Years Old with Type 2 Diabetes and Mild Renal Insufficiency
A. Raji, Zhi-Jin Xu, Raymond L. H. Lam, E. A. O'Neill +2 more
2020Diabetes Therapy16 citations Open access
Semantic Scholar
A randomized, double-blind, non-inferiority trial evaluating the efficacy and safety of omarigliptin, a once-weekly DPP-4 inhibitor, or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy
Y. Handelsman, Brett Lauring, I. Gantz, Carol Iredale +6 more
2017Current Medical Research and Opinion15 citations
Semantic Scholar
Efficacy and safety of metformin and sitagliptin based triple antihyperglycemic therapy (STRATEGY): a multicenter, randomized, controlled, non-inferiority clinical trial
Wen Xu, Y. Mu, Jia-Jun Zhao, Da-Long Zhu +14 more
2017Science China Life Sciences14 citations
Semantic Scholar
A randomized clinical trial evaluating the efficacy and safety of the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy
R. Shankar, Silvio E. Inzucchi, Victoria Scarabello, I. Gantz +5 more
2017Current Medical Research and Opinion13 citations
Semantic Scholar
A randomized clinical trial of the safety and efficacy of sitagliptin in patients with type 2 diabetes mellitus inadequately controlled by acarbose alone
Wei-Qing Wang, G. Ning, Jianhua Ma, Xiao-Min Liu +8 more
2017Current Medical Research and Opinion13 citations
Semantic Scholar
A randomized, double-blind trial evaluating the efficacy and safety of monotherapy with the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in people with type 2 diabetes.
P. Home, R. Shankar, I. Gantz, Carol Iredale +7 more
2017Diabetes Research and Clinical Practice12 citations Open access
Semantic Scholar
Efficacy and safety of metformin and sitagliptin‐based dual and triple therapy in elderly Chinese patients with type 2 diabetes: Subgroup analysis of STRATEGY study
Xiang-Yang Liu, Li Wang, Y. Xing, S. Engel +9 more
2020Journal of Diabetes Investigation11 citations Open access
Semantic Scholar
Hypertension Control in Adults With Diabetes and Recurrent Cardiovascular Events: Global Results From the TECOS Trial
A. Navar, D. Gallup, Y. Lokhnygina, J. Green +9 more
2017HYPERTENSION11 citations Open access
Semantic Scholar
Comorbidities in type 2 diabetes patients with and without atherosclerotic cardiovascular disease: a retrospective database analysis
K. Iglay, Hakima Hannachi, S. Engel, Xueying Li +3 more
2021Current Medical Research and Opinion10 citations
Semantic Scholar
A randomized, placebo-controlled clinical trial evaluating the safety and efficacy of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus inadequately controlled by glimepiride and metformin
Seung-Hwan Lee, I. Gantz, E. Round, M. Latham +6 more
2017BMC Endocrine Disorders10 citations Open access
Semantic Scholar
Double‐blind, randomized clinical trial assessing the efficacy and safety of early initiation of sitagliptin during metformin uptitration in the treatment of patients with type 2 diabetes: The CompoSIT‐M study
J. Frias, Z. Zimmer, Raymond L. H. Lam, G. Amorin +7 more
2019Diabetes, obesity and metabolism9 citations Open access
Semantic Scholar
Progression of glucose‐lowering diabetes therapy in TECOS
M. Bethel, S. Engel, Susanna R. Stevens, Y. Lokhnygina +7 more
2018Endocrinology, Diabetes & Metabolism9 citations Open access
Semantic Scholar
Impact of differing glucose‐lowering regimens on the pattern of association between glucose control and survival
C. Currie, S. Holden, S. Jenkins-Jones, C. Morgan +5 more
2017Diabetes, obesity and metabolism9 citations Open access
Semantic Scholar
Comparison of Treatment with Sitagliptin or Sulfonylurea in Patients with Type 2 Diabetes Mellitus and Mild Renal Impairment: A Post Hoc Analysis of Clinical Trials
E. Ommen, Lei Xu, E. A. O'Neill, B. Goldstein +2 more
2015Diabetes Therapy9 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

K. Kaufman×20
Invite
K. Kaufman — researcher profile on SciRah
E. A. O'Neill×13
Invite
E. A. O'Neill — researcher profile on SciRah
S. Suryawanshi×12
Invite
S. Suryawanshi — researcher profile on SciRah
S. Rajpathak×9
Invite
S. Rajpathak — researcher profile on SciRah

×9

Invite

I. Gantz — researcher profile on SciRah

Invite

R. Holman — researcher profile on SciRah

Invite

K. Iglay — researcher profile on SciRah

Invite

G. Golm — researcher profile on SciRah

Invite

E. Lai — researcher profile on SciRah

Invite

J. Green — researcher profile on SciRah

Invite

M. Bethel — researcher profile on SciRah

Invite

R. Josse — researcher profile on SciRah